Korean J Gastroenterol.  2018 May;71(5):282-285. 10.4166/kjg.2018.71.5.282.

Management of Patients on Antithrombotic Agents Undergoing Endoscopy

• Kim JS
• Kim BW

• KMID: 2415486
• DOI: http://doi.org/10.4166/kjg.2018.71.5.282

Abstract

Antithrombotic agents are used increasingly in Asia. The management of patients on antithrombotics undergoing elective or emergency endoscopy has become an increasing clinical challenge for gastroenterologists. Current practice guidelines have been developed by societies from western countries. On the other hand, these guidelines cannot meet the specific needs of the Asian Pacific region, raising the need for separate guidelines in Asia. This review compares the recommendations of previous guidelines with the most recently published Asian guidelines regarding the management of patients on antithrombotic agents undergoing elective and emergency endoscopy.

Keyword

Antithrombotic agents; Endoscopy; Guideline

MeSH Terms

Asia
Asian Continental Ancestry Group
Emergencies
Endoscopy*
Fibrinolytic Agents*
Hand
Humans
Fibrinolytic Agents

Reference

References

1. Abraham NS. Gastrointestinal bleeding in cardiac patients: epidemiology and evolving clinical paradigms. Curr Opin Gastroenterol. 2014; 30:609–614.

2. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2015; 47:a1–a46.

3. ASGE Standards of Practice Committee. Acosta RD, Abraham NS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016; 83:3–16.

4. Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016; 48:385–402.

5. Chan FKL, Goh KL, Reddy N, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut. 2018; 67:405–417.

6. Zakko L, Rustagi T, Douglas M, Laine L. No benefit from platelet transfusion for gastrointestinal bleeding in patients taking anti-platelet agents. Clin Gastroenterol Hepatol. 2017; 15:46–52.

7. Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation. 2009; 119:1634–1642.

8. Shingina A, Barkun AN, Razzaghi A, Martel M, Bardou M, Gralnek I. Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding. Aliment Pharmacol Ther. 2011; 33:1010–1018.

9. Crowther MA, Julian J, McCarty D, et al. Treatment of warfar-in-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet. 2000; 356:1551–1553.

10. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy. 2000; 20:1159–1166.

11. Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013; 310:1462–1472.

12. Douketis JD, Healey JS, Brueckmann M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin inter-ruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost. 2015; 113:625–632.